IngenioRx, UC’s new pharmacy benefit plan manager, to begin on May 1
On May 1, 2019, IngenioRx (an Anthem company) will replace ExpressScripts as the pharmacy benefit plan manager for UC medical plan members
On May 1, 2019, IngenioRx (an Anthem company) will replace ExpressScripts as the pharmacy benefit plan manager for UC medical plan members. This transition will provide UC medical plan members with 24/7/365 customer service access along with improved online services and information.
There are no changes to UC medical or pharmacy plans as a result of this change and plan members can continue to use the same retail pharmacies used today for pharmacy purchases. Individuals currently taking advantage of home delivery or who use specialty medications will receive additional communications directly from Anthem in the coming weeks.
Additional information is available on the Anthem Medical Plan Options page.
Questions?
Plan members with questions are welcome to contact Anthem at the phone number on their ID card.
Have additional questions? Reach out to the UC Benefits team at benefits@uc.edu or call 513-556-6381.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.